Nyxoah SA (NYXH)
10.43
+0.16
(+1.56%)
USD |
NASDAQ |
May 16, 16:00
10.25
-0.18
(-1.73%)
After-Hours: 20:00
Nyxoah Price to Book Value: 2.761 for May 16, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 16, 2024 | 2.761 |
| May 15, 2024 | 2.719 |
| May 14, 2024 | 2.536 |
| May 13, 2024 | 2.343 |
| May 10, 2024 | 2.179 |
| May 09, 2024 | 2.255 |
| May 08, 2024 | 2.459 |
| May 07, 2024 | 2.390 |
| May 06, 2024 | 2.390 |
| May 03, 2024 | 2.584 |
| May 02, 2024 | 2.629 |
| May 01, 2024 | 2.510 |
| April 30, 2024 | 2.738 |
| April 29, 2024 | 2.930 |
| April 26, 2024 | 2.811 |
| April 25, 2024 | 2.989 |
| April 24, 2024 | 2.810 |
| April 23, 2024 | 2.774 |
| April 22, 2024 | 2.806 |
| April 19, 2024 | 2.846 |
| April 18, 2024 | 2.753 |
| April 17, 2024 | 2.528 |
| April 16, 2024 | 2.462 |
| April 15, 2024 | 2.356 |
| April 12, 2024 | 2.385 |
| Date | Value |
|---|---|
| April 11, 2024 | 2.573 |
| April 10, 2024 | 2.872 |
| April 09, 2024 | 2.912 |
| April 08, 2024 | 2.997 |
| April 05, 2024 | 3.179 |
| April 04, 2024 | 3.235 |
| April 03, 2024 | 3.312 |
| April 02, 2024 | 3.071 |
| April 01, 2024 | 3.245 |
| March 28, 2024 | 3.571 |
| March 27, 2024 | 3.510 |
| March 26, 2024 | 3.539 |
| March 25, 2024 | 3.590 |
| March 22, 2024 | 3.897 |
| March 21, 2024 | 3.942 |
| March 20, 2024 | 3.680 |
| March 19, 2024 | 4.429 |
| March 18, 2024 | 5.162 |
| March 15, 2024 | 4.380 |
| March 14, 2024 | 4.388 |
| March 13, 2024 | 4.533 |
| March 12, 2024 | 4.631 |
| March 11, 2024 | 4.499 |
| March 08, 2024 | 4.239 |
| March 07, 2024 | 3.938 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.8753
Minimum
Feb 21 2023
9.290
Maximum
Aug 06 2021
2.922
Average
1.851
Median
Jul 20 2023
Price to Book Value Benchmarks
| Galapagos NV | 0.6229 |
| UCB SA | 2.519 |
| Mithra Pharmaceuticals SA | -- |
| Celyad Oncology SA | -- |
| MDxHealth SA | -- |
Price to Book Value Related Metrics
| PS Ratio | 61.94 |
| PEG Ratio | -0.1907 |
| Price | 10.43 |
| Earnings Yield | -16.10% |
| Market Cap | 299.16M |
| PEGY Ratio | -0.1907 |